{"id":"NCT01001494","sponsor":"AstraZeneca","briefTitle":"Efficacy and Safety of Aclidinium Bromide at Two Dose Levels Versus Placebo Administered in Chronic Obstructive Pulmonary Disease (COPD) Patients","officialTitle":"Efficacy and Safety of Aclidinium Bromide at Two Dose Levels vs Placebo When Administered to Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD)","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2009-10","primaryCompletion":"2010-11","completion":"2010-11","firstPosted":"2009-10-26","resultsPosted":"2012-09-17","lastUpdate":"2017-01-04"},"enrollment":828,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"DOUBLE","primaryPurpose":"TREATMENT"},"conditions":["Chronic Obstructive Pulmonary Disease (COPD)"],"interventions":[{"type":"DRUG","name":"Aclidinium bromide 200 μg bid","otherNames":[]},{"type":"DRUG","name":"Aclidinium bromide 400 μg bid","otherNames":[]},{"type":"DRUG","name":"Placebo","otherNames":[]}],"arms":[{"label":"Aclidinium bromide 200 μg bid","type":"EXPERIMENTAL"},{"label":"Aclidininum bromide 400 μg bid","type":"EXPERIMENTAL"},{"label":"Placebo","type":"PLACEBO_COMPARATOR"}],"summary":"The main purpose of this study is to assess the long term bronchodilator efficacy, safety and tolerability of inhaled aclidinium bromide at two dose levels compared to placebo in COPD patients and the benefits of the product in disease-related health status, COPD symptoms and COPD exacerbations.","primaryOutcome":{"measure":"Change From Baseline in Morning Pre-dose (Trough) Forced Expiratory Volume in the First Second (FEV1) at Week 24 on Treatment","timeFrame":"Baseline and Week 24","effectByArm":[{"arm":"Aclidinium Bromide 200 μg Bid","deltaMin":0.026,"sd":0.016},{"arm":"Aclidinium Bromide 400 μg Bid","deltaMin":0.055,"sd":0.016},{"arm":"Placebo","deltaMin":-0.073,"sd":0.016}],"pValues":[]},"eligibility":{"minAge":"40 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":3,"exclusionCount":4},"locations":{"siteCount":106,"countries":["Czechia","France","Germany","Hungary","Italy","Peru","Poland","Russia","South Africa","Spain","Ukraine"]},"refs":{"pmids":["28074135","27215749","25234803","22441743"],"seeAlso":["http://www.almirall.com/webcorp2/cda/ImD_04_02.jsp"]},"adverseEventsSummary":{"seriousAny":{"events":12,"n":277},"commonTop":["Chronic obstructivce pulmonary disease","Headache","Nasopharyngitis"]}}